Rosamaria Orlando

Pubblicazioni

Titolo Pubblicato in Anno
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease NPJ PARKINSON'S DISEASE 2025
Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach CURRENT NEUROPHARMACOLOGY 2024
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders NEUROPHARMACOLOGY 2023
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism NEUROPHARMACOLOGY 2023
Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in Mice LIFE 2022
Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons FRONTIERS IN PHARMACOLOGY 2022
mGlu3 receptor regulates microglial cell reactivity in neonatal rats JOURNAL OF NEUROINFLAMMATION 2021
The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice PHARMACOLOGICAL RESEARCH 2021
MGlu3 receptor regulates microglial cell reactivity in neonatal rats. JOURNAL OF NEUROINFLAMMATION 2021
Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia FRONTIERS IN PSYCHIATRY 2019
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia FRONTIERS IN PSYCHIATRY 2019
Targeting metabotropic glutamate receptors in the treatment of primary brain tumors CURRENT OPINION IN PHARMACOLOGY 2018
Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system NEUROPHARMACOLOGY 2018
Targeting mGlu5 metabotropic glutamate receptors in the treatment of cognitive dysfunction in a mouse model of phenylketonuria FRONTIERS IN NEUROSCIENCE 2018
Stress as risk factor for Alzheimer's disease PHARMACOLOGICAL RESEARCH 2018
In vivo non-radioactive assessment of mGlu5 receptor-activated polyphosphoinositide hydrolysis in response to systemic administration of a positive allosteric modulator. FRONTIERS IN PHARMACOLOGY 2018
Targeting metabotropic glutamate receptors in the treatment of primary brain tumors CURRENT OPINION IN PHARMACOLOGY 2018
Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus PHARMACOLOGICAL RESEARCH 2017
Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling NEUROPHARMACOLOGY 2017
Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling NEUROPHARMACOLOGY 2017

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma